Drug Utilization Review Board
Meeting Agenda
Thursday, March 09, 2023
7:15 a.m. to 8:30 a.m.
Google Meet joining info
Video call link: https://meet.google.com/gty-zdat-upx
Or dial: (US) +1 904-900-0129 PIN: 716 857 352 #
Persons who wish to address the DUR Board may contact Ngan Huynh at (nhuynh@utah.gov) prior to the meeting, or sign up to provide comments at the meeting. Public comments will be limited to 3 minutes per speaker or organization due to time constraints.
1) Call to order - Eric Cannon, PharmD
a) Announce Quorum
2) Welcome and Introductions - Eric Cannon, PharmD
a) Housekeeping
b) Review and Approval of Minutes
3) Review
a) Adult Pulmonary Arterial Hypertension - University of Utah DRRC
i) Public Comment
1) United Therapeutics - Tyvaso - Kimberly Simpson, PharmD
2) Janssen Pharmaceutical - Adrian Lau, PharmD
ii) Committee Discussions/Questions/Action
a) Adult Pulmonary Arterial Hypertension - University of Utah DRRC
i) Committee Discussion/Questions/Action
4) Next Meeting
a) April 13th, 2023 - Pediatric Pulmonary Arterial Hypertension
5) Adjourned
Notice of Special Accommodations (ADA)
In compliance with the Americans with Disabilities Act, individuals needing special accommodations (including auxiliary communicative aids and services) during this meeting should notify Ngan Huynh at 801-538-6014.
Notice of Electronic or Telephone Participation
Google Meet joining info
Video call link: https://meet.google.com/gty-zdat-upx
Or dial: (US) +1 904-900-0129 PIN: 716 857 352 #